Chronic lymphocytic leukemia (CLL) cells located in proliferation centers are constantly stimulated by accessory cells, which provide them with survival and proliferative signals and mediate ...
Please provide your email address to receive an email when new articles are posted on . Survivin, an inhibitor of apoptosis protein, may be an attractive target for a variety of immunotherapeutic ...
Translational data confirms survivin-specific CD8+ T cell immune response in 87% of subjects which supports a direct link with DPX-Survivac’s mechanism of action DARTMOUTH, Nova Scotia--(BUSINESS WIRE ...
Survivin positivity and expression levels were correlated with histopathologic features of the tumors, apoptosis (as measured by cleaved, or activated, caspase 3 levels), and clinical outcome. RESULTS ...
Survival and Late Effects in Children With Hodgkin's Lymphoma Treated With MOPP/ABV and Low-Dose, Extended-Field Irradiation Immunohistopathologic studies were carried out on 26 tumor samples from a ...
Survivin regulates cell division and inhibits apoptosis by blocking caspase activation. The tumor suppressor p53 inhibits cell cycle progression and induces apoptosis. Since Survivin overexpression ...
Novel Means of Leveraging Cellular Therapy to "Teach" Immune System to Seek and Destroy Cancer SAN DIEGO, July 26, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), ...
Erlanger Health System announces registration is now open for the first ever Survivin’ and Thrivin’, a cancer survivorship symposium, to be held on Saturday, Sept. 17. This inaugural event is designed ...
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of targeted cancer immunotherapies and vaccines against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results